TXG Stock: 10x Genomics, Inc. Stock Price, Analysis & Insights
Get live TXG stock price $29.45, comprehensive 10x Genomics, Inc. stock analysis, charts, news, and expert forecast. Real-time TXG stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated inst...
Company Information
- CEO
- Serge Saxonov
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 1306
Contact Information
- Website
- https://www.10xgenomics.com
- Address
- 6230 Stoneridge Mall Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 2.11)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for 10x Genomics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for 10x Genomics, Inc.
- ⚠Investors should consider how 10x Genomics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
3.74B
P/E Ratio (TTM)
-173.22
Beta
2.11
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare TXG with peer companies:
- Price
- $5.19
- Market cap
- 807.38M
- Price
- $42.24
- Market cap
- 2.67B
- Price
- $13.22
- Market cap
- 806.10M
- Price
- $4.69
- Market cap
- 1.63B
- Price
- $38.84
- Market cap
- 1.77B
- Price
- $17.33
- Market cap
- 1.03B
- Price
- $25.97
- Market cap
- 2.03B
- Price
- $14.21
- Market cap
- 1.06B
- Price
- $33.66
- Market cap
- 1.52B
- Price
- $7.02
- Market cap
- 1.27B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.